NCT06602635

Brief Summary

Outflow tract ventricular arrhythmia (OTVA) is the most common type of ventricular arrhythmia, and catheter ablation (CA) is the primary treatment option for patients experiencing symptoms. Accurately identifying the origin site of OTVA is essential for effective catheter ablation, minimizing procedural risks, and enhancing treatment success. However, most studies that developed algorithms or scoring systems for distinguishing OTVA origins excluded participants with structural heart disease and those with paced rhythms from their study groups. A recent prospective evaluation of a hybrid score (HS) that integrates both clinical and ECG data to predict OTVA-SOO, including patients with cardiac implantable electronic devices and those with structural heart disease in our study. The presented study aimed to assess the effectiveness of the previously described hybrid algorithm in predicting OTVA-SOO in a patient population characterized by a wide basal QRS due to intraventricular conduction defects or paced rhythms. The Hybrid Score The Hybrid Score (HS), involves a sum of points based on clinical and ECG characteristics. Points are assigned as follows: one point each for being over 50 years old, male, and having arterial hypertension. ECG-based points are allocated according to QRS transition: 3 points for a transition in V1, 2 points for V2, 1 point for V3 if the R-wave in V3 is greater than 1 mV; 1 point is subtracted if V3 has an R-wave less than 1 mV, and further deductions or additions apply for transitions up to V6. A score ≤ 1 suggests an RVOT origin, whereas ≥ 2 suggests an LVOT origin. ECGs were recorded with a standard configuration at a 25 mm/s sweep speed. Premature Ventricular Contraction (PVC) Ablation Activation mapping of spontaneous OTVAs was conducted. The procedure aimed to abolish spontaneous OTVAs, with the site of ablation marking the site of origin (SOO). Collected data

  • Patient Information and Consent (procedure must be done within 60 days of consent)
  • Demographics (age, gender, etc.)
  • Vital signs (length, weight, etc.)
  • Medical history, including cardiovascular risk factors, cardiomyopathy and drugs
  • ECG data
  • Echocardiographic data (left ventricular ejection fraction and left ventricular end-diastolic diameter)
  • Procedure data (number of radiofrequency applications, site of effective ablation, total radiofrequency time, total fluoro time, points mapping, procedure time)
  • Adverse Events

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2022

Typical duration for all trials

Geographic Reach
3 countries

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 4, 2022

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

September 9, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
23 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 23, 2024

Completed
Last Updated

September 24, 2024

Status Verified

September 1, 2024

Enrollment Period

2.7 years

First QC Date

September 9, 2024

Last Update Submit

September 21, 2024

Conditions

Keywords

Ventricular extrasystolePremature ventricular complexecgoutflow tract ventricular arrhythmias

Outcome Measures

Primary Outcomes (1)

  • Hybrid score performance

    The primary endpoint of the study is to establish the sensibility and specificity of an already validated clinical and electrocardiographic score for the prediction of left or right outflow tract ventricular arrhythmias in a selected population with large QRS because of intraventricular conduction disorders or paced rhythm who underwent catheter ablation of the arrhythmia.

    At the moment of interventional procedure

Secondary Outcomes (1)

  • Safety

    1 month after the procedure date

Study Arms (2)

RVOT origin

Patients with right ventricular outflow tract (RVOT) arrhythmias origin

Diagnostic Test: ECG and clinical score

LVOT origin

Patients with left ventricular outflow tract (LVOT) arrhythmias origin

Diagnostic Test: ECG and clinical score

Interventions

ECG and clinical scoreDIAGNOSTIC_TEST

The Hybrid Score (HS), detailed in previous literature involves a sum of points based on clinical and ECG characteristics. Points are assigned as follows: one point each for being over 50 years old, male, and having arterial hypertension. ECG-based points are allocated according to QRS transition: 3 points for a transition in V1, 2 points for V2, 1 point for V3 if the R-wave in V3 is greater than 1 mV; 1 point is subtracted if V3 has an R-wave less than 1 mV, and further deductions or additions apply for transitions up to V6. A score ≤ 1 suggests an RVOT origin, whereas ≥ 2 suggests an LVOT origin.

LVOT originRVOT origin

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

General population undergoing catheter ablation for outflow tract ventricular arrhythmias

You may qualify if:

  • ventricular arrhythmia with a morphology indicating an outflow tract origin and a wide basal QRS complex
  • a QRS width greater than 110 ms was considered wide
  • willing and capable of providing written informed consent to the study

You may not qualify if:

  • catether ablation procedure was unsuccessful
  • infrequent arrhythmia requiring ablation guided by pacemapping.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Vrije Universiteit Brussel

Brussels, Belgium, 1090, Belgium

RECRUITING

Maria Cecilia Hospital

Cotignola, Italy, 48033, Italy

RECRUITING

Niguarda Ca Granda Hospital

Milan, Italy, 20132, Italy

RECRUITING

Cisanello University Hospital (Pisa, Italy)

Pisa, Italy, 56124, Italy

RECRUITING

Teknon Medical Center

Barcelona, Spain, 08022, Spain

RECRUITING

Hospital Universitario Puerta del Mar

Cadiz, Spain, 11009, Spain

RECRUITING

Related Publications (2)

  • Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, Reichlin T, Schulz-Menger J, Sticherling C, Tzeis S, Verstrael A, Volterrani M; ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262. No abstract available.

    PMID: 36017572BACKGROUND
  • Anderson RD, Kumar S, Parameswaran R, Wong G, Voskoboinik A, Sugumar H, Watts T, Sparks PB, Morton JB, McLellan A, Kistler PM, Kalman J, Lee G. Differentiating Right- and Left-Sided Outflow Tract Ventricular Arrhythmias: Classical ECG Signatures and Prediction Algorithms. Circ Arrhythm Electrophysiol. 2019 Jun;12(6):e007392. doi: 10.1161/CIRCEP.119.007392. Epub 2019 Jun 4.

    PMID: 31159581BACKGROUND

MeSH Terms

Conditions

Ventricular Premature Complexes

Interventions

Electrocardiography

Condition Hierarchy (Ancestors)

Cardiac Complexes, PrematureArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Central Study Contacts

Antonio Berruezo, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

September 9, 2024

First Posted

September 19, 2024

Study Start

January 4, 2022

Primary Completion

September 30, 2024

Study Completion

October 23, 2024

Last Updated

September 24, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations